Log In

The first prospective trial for von Hippel-Lindau disease: pazopanib

Files

1-s2.0-S1470204518305333-main.pdf (268.07 KB)

Publication date

2018-10

Authors

Giles, RISNI 0000000398612082
Gläsker, Sven

Editors

Advisors

Supervisors

DOI

https://doi.org/10.1016/S1470-2045(18)30533-3

Document Type

Comment

Metadata

Show full item record

Collections

UMC Repository
Open Access logo

License

taverne

Abstract

Keywords

Journal Article, Pyrimidines, Prospective Studies, Sulfonamides, Humans, von Hippel-Lindau Disease, Taverne, Oncology, Comment, Journal Article

Citation

Giles, R H & Gläsker, S 2018, 'The first prospective trial for von Hippel-Lindau disease : pazopanib', LANCET ONCOLOGY, vol. 19, no. 10, pp. 1267-1269. https://doi.org/10.1016/S1470-2045(18)30533-3

URI

https://dspace.library.uu.nl/handle/1874/463740